NDC 65250-002 - Zilretta

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 65250-002
Package NDCs from labels: 65250-002-01
Manufacturer: Pacira Pharmaceuticals, Inc.
Effective date: 2026-06-03
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
triamcinolone acetonide extended-release injectable suspension	Pacira Pharmaceuticals, Inc.	2026-06-03	HUMAN PRESCRIPTION DRUG LABEL

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
65250-002	ZILRETTA (TRIAMCINOLONE ACETONIDE EXTENDED-RELEASE INJECTABLE SUSPENSION) KIT [PACIRA PHARMACEUTICALS, INC.]	4	Unmatched	20250112_cd5c4673-21f2-4126-9556-da847b3a228b.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 13 of 13 · 242 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Triamcinolone Acetonide	TRIAMCINOLONE ACETONIDE	Glenmark Pharmaceuticals Inc., USA	8c380328-127b-4ca6-bf56-ef461e704471	2017-08-22	Adverse reactions	Exact identifier unii: F446C597KA
Triamcinolone Acetonide	TRIAMCINOLONE ACETONIDE	Glenmark Pharmaceuticals Inc., USA	a9b3764d-fd3d-4fcc-8d22-5aa848da1b06	2016-07-11	Adverse reactions	Exact identifier unii: F446C597KA

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.